Profile: BioVascular Inc. is a biotechnology company that develops drugs & devices for the control of intimal hyperplasia associated with vascular procedures and control of risk factors associated with cardiovascular morbidity & mortality. We offer saratin, which is a polypeptide produced by recombinant means in yeast. We also develop a sustained release formulation for a novel small molecule to address a recently identified cardiovascular risk factor.